Status:
UNKNOWN
The Effect of Human Albumin on Coagulation Competence and Hemorrhage
Lead Sponsor:
Kirsten Cleemann Rasmussen
Conditions:
Hemorrhage; Complicating Delivery, Coagulation Defect
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
In a randomized clinical trial, the purpose is to investigate if perioperative coagulation and hemorrhage is influenced by colloid or crystalloid.
Detailed Description
5% Human Albumin is used for fluid therapy during surgery. This study evaluate whether affected coagulation competence induced by Human Albumin leads to a significant perioperative blood loss when com...
Eligibility Criteria
Inclusion
- Patient more than 18 years old
- Indication for elective post-renal operation including cystectomy
- Patient without anticoagulative, acetylsalicylic acid or nonsteroidal antiinflammatory drug
- treatment for the last 5 days
Exclusion
- Intracerebral bleeding, manifest cardiac insufficient, renal insufficient demanding dialysis, hepatic or coagulation diseases
- Pregnant or nursing
- Allergic to Human Albumin
- Disturbance in electrolytes
- Patient under committee
- Patient joining another trial interfering the actual trial
Key Trial Info
Start Date :
August 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 1 2015
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT02270723
Start Date
August 1 2014
End Date
November 1 2015
Last Update
October 21 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rigshospitalet
Copenhagen, Denmark, 2100